CAS NO: | 1862212-48-3 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | TH1217 (ZINC1775962367) is a potent and selectivedCTPase pyrophosphatase 1 (dCTPase)inhibitor, with anIC50of 47 nM. TH1217 enhances the cytotoxic effect of cytidine analogues in leukemia cells. TH1217 also could modulate SARS-Cov-2 interactors, so it shows activity of against COVID-19[1][2]. | ||||||||||||||||
IC50& Target | IC50: 47 nM (dCTPase)[1] | ||||||||||||||||
体外研究 (In Vitro) | TH1217 (compound 30) inhibits dCTPase and enhances aqueous solubility (>100 μM) and improves plasma stability in vitro(t4h=86%)[1]. | ||||||||||||||||
分子量 | 491.09 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H17BCl2N4O6 | ||||||||||||||||
CAS 号 | 1862212-48-3 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 125 mg/mL(254.54 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |